REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study.

Christian Domingo RibasTeresa Carrillo DíazMarina Blanco AparicioEva Martínez MoragónDavid Banas ConejeroM Guadalupe Sánchez Herreronull null

Published in: Drugs (2021)

This real-world study of SEA patients confirms that mepolizumab is effective in reducing clinically meaningful exacerbations, improving lung function, and decreasing OCS dependence and mean OCS dose at 12 months, irrespective of baseline eosinophil counts.

Keyphrases

lung function
chronic obstructive pulmonary disease
ejection fraction
newly diagnosed
cystic fibrosis
prognostic factors
patient reported outcomes